We analyzed the correlation between the expression of GATA3, UTX, and Dicer and the clinical outcomes of patients with breast cancer: Kaplan–Meier survival analysis performed in relation to GATA3, UTX, and Dicer by using an online tool (http://kmplot.com/analysis/) revealed that elevated expression of any of the 3 molecules was associated with enhanced overall survival of breast cancer patients (Fig. 7a). The gene discussed is KDM6A; the disease is breast carcinoma.